MedPath

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Not Applicable
Completed
Conditions
Glomerulonephritis, IGA
Registration Number
NCT00521508
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Along structural IgA abnormalities, hyperproduction of IgA is thought to play a role in the pathogenesis of primary IgA nephropathy. CD4+CD25+Fox3P regulatory T cells are instrumental in suppressing adaptative immune responses, including B cells production of immunoglobulins. We, the researchers at Centre Hospitalier Universitaire de Saine Etienne, will test the hypothesis that IgA production in patients with IgA nephropathy is dysregulated because of a quantitative and/or qualitative defect of CD4+CD25+FoxP3+ regulatory T cells.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Patients with pathogenesis of Berger's disease confirmed by renal biopsy
  • Glomerular filtration > 60 ml/min/1,73m2
  • Written informed consent
  • Patient affiliated to social insurance
Exclusion Criteria
  • Immunosuppressor treatment within 6 months before the study inclusion
  • Clinical infection within 2 months before the study inclusion
  • C-reactive protein (CRP) > 10 mgL-1

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
proportion averages of cells CD4+CD25+CD127 low T in peripheral bloodinclusion
Secondary Outcome Measures
NameTimeMethod
average relative expression of genes FoxP3, CTLA4, GITR, IL10, TGF-B, OX40, TIM-1, and TIM-3inclusion

Trial Locations

Locations (1)

Nephrology Unit Hôpital Nord CHU de Saint-Etienne

🇫🇷

Saint-Etienne, France

Nephrology Unit Hôpital Nord CHU de Saint-Etienne
🇫🇷Saint-Etienne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.